Effect of compressive force on the production of prostaglandin E2 and its receptors in osteoblastic Saos-2 cells

Connective Tissue Research

Volumn 48, Issue 5, 2007, Pages 246-253

  Sanuki, Rina ^a   Mitsui, Narihiro ^a   Suzuki, Naoto ^a   Koyama, Yuki ^a   Yamaguchi, Akikuni ^a   Isokawa, Keitaro ^a   Shimizu, Noriyoshi ^a   Maeno, Masao ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Mechanical Stress; Osteoblasts; PGE receptors; PGE2; Protein Kinase A

Indexed keywords

CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ARTICLE; BONE REMODELING; CALCIUM CELL LEVEL; COMPRESSIVE STRENGTH; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

CALCIUM; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; HUMANS; OSTEOBLASTS; PHOSPHORYLATION; RECEPTORS, PROSTAGLANDIN E; STRESS, MECHANICAL;

EID: 34648828632     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200701541775     Document Type: Article

References (44)

1. Krishnan, V. and Davidovitch, Z. (2006) Cellular, molecular, and tissue-level reactions to orthodontic force. Am. J. Orthod. Dentofacial Orthop., 129:469, pp. 1-32.
2. Yamasaki, K., Shibata, Y. and Fukuhara, T. (1982) The effect of prostaglandins on experimental tooth movement in monkeys (Macaca fuscata). J. Dent. Res., 61, pp. 1444-1446.
3. Yamasaki, K., Shibata, Y., Imai, S., Tani, Y., Shibasaki, Y. and Fukuhara, T. (1984) Clinical application of prostaglandin E1 (PGE1) upon orthodontic tooth movement. Am. J. Orthod., 85, pp. 508-518.
4. Lee, W. (1990) Experimental study of the effect of prostaglandin administration on tooth movement - with particular emphasis on the relationship to the method of PGE1 administration. Am. J. Orthod. Dentofacial Orthop., 98, pp. 231-241.
5. Leiker, B. J., Nanda, R. S., Currier, G. F., Howes, R. I. and Sinha, P. K. (1995) The effects of exogenous prostaglandins on orthodontic tooth movement in rats. Am. J. Orthod. Dentofacial Orthop., 108, pp. 380-388.
6. Klein, D. C. and Raisz, L. G. (1970) Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology, 86, pp. 1436-1440.
7. 2 on macrophages and osteoclasts in cultured fetal long bones. Cell Tissue Res., 207, pp. 341-346.
8. 2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. Bone Miner., 7, pp. 255-266.
9. 4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone, 30, pp. 159-163.
10. Akatsu, T., Takahashi, N., Udagawa, N., Imamura, K., Yamaguchi, A., Sato, K., Nagata, N. and Suda, T. (1991) Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Miner. Res., 6, pp. 183-189.
11. 2 on orthodontic tooth movement. Am. J. Orthod. Dentofacial Orthop., 125, pp. 607-614.
12. 2 production and decreasing OPG production by osteoblasts. Life Sci., 77, pp. 615-626.
13. 2 production by osteoblasts. Life Sci., 78, pp. 1733-1740.
14. 2 and the receptor Ep4 in osteoblasts. Life Sci., 78, pp. 2012-2018.
15. Shoji, M., Tanabe, N., Mitsui, N., Suzuki, N., Takeichi, O., Katono, T., Morozumi, A. and Maeno, M. (2007) Lipopolysaccharide enhances the production of nicotine-induced prostaglandin E2 via an increase in cyclooxygenase-2 expression in osteoblasts. Acta Biochim. Biophys. Sin., 39, pp. 163-172.
16. 2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology, 128, pp. 2895-2900.
17. 2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif. Tissue Int., 67, pp. 85-92.
18. 2 production appropriately. Life Sci., 77, pp. 3168-3182.
19. Suzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S. and Suda, T. (2000) The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: An analysis using specific agonists for the respective EPs. Endocrinology, 141, pp. 1554-1559.
20. 2 in osteoblastic cell lines and adult rat bone tissue. Bone, 28, pp. 275-281.
21. Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A. and Narumiya, S. (1992) Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem., 267, pp. 6463-6466.
22. Watabe, A., Sugimoto, Y., Honda, A., Irie, A., Namba, T., Negishi, M., Ito, S., Narumiya, S. and Ichikawa, A. (1993) Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem., 268, pp. 20175-20178.
23. Katsuyama, M., Nishigaki, N., Sugimoto, Y., Morimoto, K., Negishi, M., Narumiya, S. and Ichikawa, A. (1995) The mouse prostaglandin E receptor EP2 subtype: Cloning, expression, and northern blot analysis. FEBS Lett., 372, pp. 151-156.
24. Suda, M., Tanaka, K., Natsui, K., Usui, T., Tanaka, I., Fukushima, M., Shigeno, C., Konishi, J., Narumiya, S., Ichikawa, A. and Nakano, K. (1996) Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology, 137, pp. 1698-1705.
25. Li, X., Okada, Y., Pilbeam, C. C., Lorenzo, J. A., Kennedy, C. R., Breyer, R. M. and Raisz, L. G. (2000) Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology, 141, pp. 2054-2061.
26. 2 in prostaglandin E receptor EP4-knockout mice. J. Biol. Chem., 275, pp. 19819-19823.
27. Sakuma, Y., Tanaka, K., Suda, M., Yasoda, A., Natsui, K., Tanaka, I., Ushikubo, F., Narumiya, S., Segi, E., Sugimoto, Y., Ichikawa, A. and Nakao, K. (2000) Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J. Bone Miner. Res., 15, pp. 218-227.
28. Fogh, J., Wright, W. C. and Loveless, J. D. (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst., 58, pp. 209-214.
29. Davidovitch, Z., Nicolay, O. F., Ngan, P. W. and Shanfeld, J. L. (1988) Neurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics. Dent. Clin. North Am., 32, pp. 411-435.
30. 2 synthesis. J. Bone Miner. Res., 17, pp. 210-220.
31. 2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. J. Bone Miner. Res., 18, pp. 1471-1477.
32. Kanai, K., Nohara, H. and Hanada, K. (1992) Initial effects of continuously applied compressive stress to human periodontal ligament fibroblasts. J. Jpn. Orthod. Soc., 51, pp. 153-163.
33. Watanabe, K., Saito, I. and Hanada, K. (1998) Effects of conditioned medium of continuously compressed human periodontal ligament fibroblasts on MC3T3-E1. J. Jpn. Orthod. Soc., 57, pp. 173-179.
34. Mitsui, N., Suzuki, N., Maeno, M., Yanagisawa, M., Koyama, Y., Otsuka, K. and Shimizu, N. (2006) Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells. Life Sci., 78, pp. 2697-2706.
35. Mitsui, N., Suzuki, N., Koyama, Y., Yanagisawa, M., Otsuka, K., Shimizu, N. and Maeno, M. (2006) Effect of compressive force on the expression of MMPs, PAs, and their inhibitors in osteoblastic Saos-2 cells. Life Sci., 79, pp. 575-583.
36. Zohar, R., Suzuki, N., Suzuki, K., Arora, P., Glogauer, M., McCulloch, C. A. G. and Sodek, J. (2000) Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell. Physiol., 184, pp. 118-130.
37. Raisz, L. G. (1999) Prostaglandins and bone: Physiology and pathophysiology. Osteoarthr. Cartil., 7, pp. 419-421.
38. Okada, Y., Lorenzo, J. A., Freeman, A. M., Tomita, M., Morham, S. G., Raisz, L. G. and Pilbean, C. C. (2000) Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J. Clin. Invest., 105, pp. 823-832.
39. Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D. and Galibert, L. (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, pp. 175-179.
40. Fuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R. and Chambers, T. J. (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med., 178, pp. 1733-1744.
41. Jimi, E., Shoto, T. and Koga, T. (1995) Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology, 136, pp. 808-811.
42. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. -S. and Lüthy, R. (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell, 89, pp. 309-319.
43. 2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: Implications for accelerated osteoclastogenesis in estrogen deficiency. J. Bone Miner. Res., 15, pp. 1321-1329.
44. 2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J. Biol. Chem., 278, pp. 28659-28667.